Burden and health care resource utilization in neovascular age-related macular degeneration -: Findings of a multicountry study

被引:114
|
作者
Soubrane, Gisele
Cruess, Alan
Lotery, Andrew
Pauleikhoff, Daniel
Mones, Jordi
Xu, Xiao
Zlateva, Gergana
Buggage, Ronald
Conlon, John
Goss, Thomas F.
机构
[1] Univ Paris 12, Dept Ophthalmol, Ctr Hosp Intercommunal, Creteil, France
[2] Dalhousie Univ, Dept Ophthalmol & Visual Sci, Halifax, NS, Canada
[3] Univ Southampton, Div Clin Neurosci, Southampton, Hants, England
[4] St Franziskus Hosp, Dept Ophthalmol, Munster, Germany
[5] Inst Microcirugia Ocular Barcelona, Barcelona, Spain
[6] Covance Market Access Serv Inc, Gaithersburg, MD USA
[7] Pfizer Ophthalm, New York, NY USA
[8] Covance Inc, Princeton, NJ USA
关键词
D O I
10.1001/archopht.125.9.1249
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Objective: To describe the burden of bilateral neovascular age-related macular degeneration (NV-AMD) on patient-reported functioning and health resource utilization. Methods: A cross-sectional study of 401 patients with bilateral NV-AMD and 471 elderly control subjects without AMD was conducted in 5 countries. Subjects completed a telephone survey, including the National Eye Institute 25-Item Visual Function Questionnaire, the EuroQol instrument, the Hospital Anxiety and Depression Scale, and history of falls, fractures, and health care resource utilization. Results: The mean age for patients with NV-AMD was 78.1 years, and 65% were women. The patients reported 45% worse vision-related functioning, 13% worse overall wellbeing, and 30% more anxiety and 42% more depression symptoms than controls after adjusting for covariates (all, P <. 001). The effect of NV-AMD was also observed as a doubled fall rate (16% vs 8% [P <. 001]) and a quadrupled need for assistance with daily activities (29% vs 7% [P <. 001]) in the patients compared with controls. Conclusions: The evidence of extensive decline in quality of life and increased need of daily living assistance for patients with NV-AMD compared with a control population substantiates the need for new treatments that prevent vision loss and progression to blindness.
引用
收藏
页码:1249 / 1254
页数:6
相关论文
共 50 条
  • [1] Humanistic burden and health resource utilization among neovascular age-related macular degeneration patients in France
    Soubrane, G.
    Zlateva, G.
    Xu, X.
    Buggage, R.
    Kosa, M.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2008, 31 (02): : 138 - 145
  • [2] Humanistic burden and health resource utilization among neovascular age-related macular degeneration (AMD) patients in France
    Soubrane, G.
    Zlateva, G.
    Xu, X.
    Goss, T. F.
    Buggage, R.
    Kosa, M.
    VALUE IN HEALTH, 2007, 10 (06) : A351 - A351
  • [3] Health resource utilization and the economic burden of patients with wet age-related macular degeneration in Thailand
    Piyameth Dilokthornsakul
    Nathorn Chaiyakunapruk
    Paisan Ruamviboonsuk
    Mansing Ratanasukon
    Somsanguan Ausayakhun
    Akrapope Tungsomeroengwong
    Nattapol Pokawattana
    Chalakorn Chanatittarat
    International Journal of Ophthalmology, 2014, (01) : 145 - 151
  • [4] Health resource utilization and the economic burden of patients with wet age-related macular degeneration in Thailand
    Dilokthornsakul, Piyameth
    Chaiyakunapruk, Nathorn
    Ruamviboonsuk, Paisan
    Ratanasukon, Mansing
    Ausayakhun, Somsanguan
    Tungsomeroengwong, Akrapope
    Pokawattana, Nattapol
    Chanatittarat, Chalakorn
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2014, 7 (01) : 145 - 151
  • [5] Burden of illness of neovascular age-related macular degeneration in Canada
    Cruess, Alan
    Zlateva, Gergana
    Xu, Xiao
    Rochon, Sophie
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2007, 42 (06): : 836 - 843
  • [6] HEALTH RESOURCE UTILIZATION AND COSTS IN PATIENTS WITH AGE-RELATED MACULAR DEGENERATION IN THAILAND: PRELIMINARY FINDINGS
    Ruamviboonsuk, P.
    Ratanasukon, M.
    Dilokthornsakul, P.
    Chanatittarat, C.
    Pokawattana, N.
    Tungsomeroengwong, A.
    Chaiyakunapruk, N.
    VALUE IN HEALTH, 2010, 13 (07) : A563 - A563
  • [7] Burden of Disease Study of Patients with Neovascular Age-Related Macular Degeneration in Spain
    Abraldes, Maximino J.
    Calvo, Pilar
    Gamez Lechuga, Maria
    Merino, Maria
    Martin Lorenzo, Teresa
    Maravilla-Herrera, Paulina
    Gil Jimenez, Beatriz
    Ruiz-Moreno, Jose M.
    OPHTHALMOLOGY AND THERAPY, 2024, 13 (07) : 1925 - 1935
  • [8] Disease Burden of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
    Almony, Arghavan
    AMERICAN JOURNAL OF MANAGED CARE, 2023, 29 (06): : S75 - S80
  • [9] Neovascular Age-Related Macular Degeneration
    Veritti, Daniele
    Sarao, Valentina
    Lanzetta, Paolo
    OPHTHALMOLOGICA, 2012, 227 : 11 - 20
  • [10] Resource utilization and costs of age-related macular degeneration
    Halpern, MT
    Schmier, JK
    Covert, D
    Venkataraman, K
    HEALTH CARE FINANCING REVIEW, 2006, 27 (03): : 37 - 47